Racey C Sarai, Gesink Dionne C, Burchell Ann N, Trivers Suzanne, Wong Tom, Rebbapragada Anu
1 Dalla Lana School of Public Health, University of Toronto , Toronto, Canada .
2 Department of Community and Family Medicine, Li Ka Shing Knowledge Institute , St. Michael's Hospital, Toronto, Canada .
J Womens Health (Larchmt). 2016 May;25(5):489-97. doi: 10.1089/jwh.2015.5348. Epub 2015 Nov 24.
Our aim was to determine if cervical cancer screening uptake would increase among under-screened women living in rural Ontario, Canada, if at-home self-collected sampling for human papillomavirus (HPV) testing was offered as a primary cervical cancer screening modality, compared to invited papanicolaou (Pap) testing or routine opportunistic screening.
Women 30-70 years of age who were overdue for cervical cancer screening were randomized to receive (1) an at-home self-collected HPV kit, (2) a reminder invitation for Pap testing, or (3) standard of care opportunistic screening. The first two arms were also asked demographic and screening history questions. Women randomized to arm 1 were asked about acceptability.
In total, 818 eligible women were identified in a small rural community in Southwestern Ontario: 335 received a self-collected HPV testing kit, 331 received a reminder letter, and 152 received standard of care. In the HPV self-collection arm, 21% (70/335) returned the sample and questionnaire and 11% (37/335) opted to undergo Pap testing. In total, 32% from the HPV self-collection arm, 15% (51/331) from the Pap invitation arm, and 8.5% (13/152) with standard of care were screened. Women receiving the self-collected HPV kit were 3.7 (95% confidence interval 2.2-6.4) times more likely to undergo screening compared to the standard of care arm. In the HPV self-sampling arm, 80% (56/70) said they would be very likely to choose self-collected sampling in the future.
Providing self-collected sampling for HPV testing was more effective than sending reminder letters to increase screening coverage in under-screened women.
我们的目的是确定,对于居住在加拿大安大略省农村地区、筛查不足的女性,如果提供在家自行采集样本进行人乳头瘤病毒(HPV)检测作为主要的宫颈癌筛查方式,与受邀进行巴氏(Pap)检测或常规机会性筛查相比,宫颈癌筛查的参与率是否会提高。
30至70岁宫颈癌筛查逾期的女性被随机分组,分别接受:(1)在家自行采集HPV检测试剂盒;(2)巴氏检测提醒邀请;或(3)标准的机会性筛查。前两组还被询问了人口统计学和筛查史问题。随机分组到第1组的女性被询问了接受程度。
在安大略省西南部的一个小农村社区共识别出818名符合条件的女性:335人收到了自行采集的HPV检测试剂盒,331人收到了提醒信,152人接受了标准护理。在HPV自行采集组中,21%(70/335)返还了样本和问卷,11%(37/335)选择进行巴氏检测。HPV自行采集组共有32%的女性接受了筛查,巴氏检测邀请组为15%(51/331),标准护理组为8.5%(13/152)。与标准护理组相比,收到自行采集HPV检测试剂盒的女性接受筛查的可能性高3.7倍(95%置信区间2.2 - 6.4)。在HPV自行采样组中,80%(56/70)表示她们未来很可能会选择自行采集样本。
提供自行采集样本进行HPV检测比发送提醒信更有效地提高了筛查不足女性的筛查覆盖率。